Patients’ view on gene therapy development for lysosomal storage disorders: a qualitative study.

[featured_image]

Download

Version
Download 948
File Size 0.00 KB
File Count 1
Create Date October 21, 2022
Last Updated December 15, 2022

Patients' view on gene therapy development for lysosomal storage disorders: a qualitative study.

Attached Files

File	Action
	Download

By Michael Foley|2022-12-15T15:07:01+00:00October 21, 2022|Comments Off

About the Author: Michael Foley

National Tay-Sachs & Allied Diseases Association (NTSAD) leads the worldwide fight to treat and cure Tay-Sachs, Canavan, GM1, and Sandhoff diseases by driving research, forging collaboration, and fostering community. Supporting families is the center of everything we do.

The content of this website is intended for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment.

The National Tay-Sachs & Allied Diseases Association (NTSAD) leads the worldwide fight to treat and cure Tay-Sachs, Canavan, GM1, and Sandhoff diseases by driving research, forging collaboration, and fostering community. Supporting families is the center of everything we do.

Community News

Get the latest news from NTSAD about our Community, the research that provides hope, and what is happening in the world of rare disease.

2001 Beacon Street, Suite 204
Boston, MA 02135
(617) 277-4463
info@ntsad.org

Tax ID
#13-1912877

National Tay-Sachs & Allied Diseases Association
2001 Beacon Street, Suite 204, Boston, MA 02135
(617) 277-4463 | info@ntsad.org